[{"Assets_0_Q3_USD":2385744000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":86511000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":86712000.0,"StockholdersEquityConverted_0_Q3_USD":755460000.0,"StockholdersEquity_0_Q3_USD":754754000.0,"RevenuesConverted_3_Q3_USD":2414270000.0,"RevenuesConverted_1_Q3_USD":810421000.0,"NetIncomeLossConverted_3_Q3_USD":582074000.0,"NetIncomeLossConverted_1_Q3_USD":175235000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":545582000.0,"EarningsPerShareDiluted_3_Q3_USD":6.71,"EarningsPerShareDiluted_1_Q3_USD":2.03,"EarningsPerShareBasic_3_Q3_USD":6.82,"EarningsPerShareBasic_1_Q3_USD":2.06,"CommonStockSharesOutstanding_0_Q3_shares":84880000.0,"CommonStockSharesConverted_0_Q3_shares":106806000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":85325000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":85123000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20211102"}]